agilon health Inc (AGL) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
agilon health Inc stock (AGL) is currently trading at $0.44. agilon health Inc PS ratio (Price-to-Sales) is 0.03. Analyst consensus price target for AGL is $0.94. WallStSmart rates AGL as Sell.
- AGL PE ratio analysis and historical PE chart
- AGL PS ratio (Price-to-Sales) history and trend
- AGL intrinsic value — DCF, Graham Number, EPV models
- AGL stock price prediction 2025 2026 2027 2028 2029 2030
- AGL fair value vs current price
- AGL insider transactions and insider buying
- Is AGL undervalued or overvalued?
- agilon health Inc financial analysis — revenue, earnings, cash flow
- AGL Piotroski F-Score and Altman Z-Score
- AGL analyst price target and Smart Rating
agilon health Inc
📊 No data available
Try selecting a different time range
Smart Analysis
agilon health Inc (AGL) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, eps growth. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
agilon health Inc (AGL) Key Strengths (4)
Paying less than $1 for every $1 of annual revenue
Earnings per share surging 1195.00% year-over-year
89.85% of shares held by major funds and institutions
Trading at 1.40x book value, attractively priced
Supporting Valuation Data
agilon health Inc (AGL) Areas to Watch (5)
Company is destroying shareholder value
Losing money on operations
Company is losing money with a negative profit margin
Revenue growing slowly at 3.10% annually
Micro-cap company with very limited liquidity and high volatility
Supporting Valuation Data
agilon health Inc (AGL) Detailed Analysis Report
Overall Assessment
This company scores 44/100 in our Smart Analysis, earning a D grade. Out of 9 metrics analyzed, 4 register as strengths (avg 9.5/10) while 5 fall into concern territory (avg 1.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, EPS Growth, Institutional Own.. Valuation metrics including Price/Sales (0.03), Price/Book (1.40) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 1195.00%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Profit Margin. Growth concerns include Revenue Growth at 3.10%, which may limit upside. Profitability pressure is visible in Return on Equity at -135.60%, Operating Margin at -9.97%, Profit Margin at -6.60%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -135.60% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 3.10% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
AGL Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
AGL's Price-to-Sales ratio of 0.03x trades at a deep discount to its historical average of 3.17x (0th percentile). The current valuation is 100% below its historical high of 13.41x set in Jun 2021, and -1% above its historical low of 0.03x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~0.3x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for agilon health Inc (AGL) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
agilon health Inc is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 5.9B with 310% growth year-over-year. The company is currently unprofitable, posting a -6.6% profit margin.
Key Findings
Revenue growing at 310% YoY, reaching 5.9B. This pace significantly outperforms most MEDICAL CARE FACILITIES peers.
Debt-to-equity ratio of 0.12 indicates a conservative balance sheet with 172M in cash.
The company is unprofitable with a -6.6% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -38M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can agilon health Inc maintain 310%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact agilon health Inc.
Bottom Line
agilon health Inc is a high-conviction growth story with revenue accelerating at 310% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin -6.6% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(8 last 3 months)
| Insider | Type | Shares |
|---|---|---|
SHAKER, BENJAMIN Chief Markets Officer | Buy | +500,000 |
| Insider | Type | Shares |
|---|---|---|
SCHWANEKE, JEFFREY A. Chief Financial Officer | Buy | +600,000 |
Data sourced from SEC Form 4 filings
Last updated: 8:26:06 AM
About agilon health Inc(AGL)
NYSE
HEALTHCARE
MEDICAL CARE FACILITIES
USA
agilon health, inc. The company is headquartered in Long Beach, California.